Profund Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-212,732
Closed -$21.1M 1355
2019
Q3
$21.1M Sell
212,732
-10,940
-5% -$1.04M 1.07% 12
2019
Q2
$20.7M Sell
223,672
-16,280
-7% -$1.55M 0.98% 14
2019
Q1
$22.6M Buy
239,952
+5,044
+2% +$441K 1.09% 13
2018
Q4
$15.1M Sell
234,908
-60,585
-21% -$4.47M 0.93% 14
2018
Q3
$26.4M Buy
295,493
+23,007
+8% +$2.03M 1% 13
2018
Q2
$21.6M Sell
272,486
-31,180
-10% -$2.59M 0.86% 17
2018
Q1
$27.1M Sell
303,666
-38,329
-11% -$3.68M 1.08% 14
2017
Q4
$35.7M Sell
341,995
-34,199
-9% -$3.86M 1.38% 10
2017
Q3
$54.9M Buy
376,194
+26,055
+7% +$3.55M 2.28% 4
2017
Q2
$45.5M Sell
350,139
-17,887
-5% -$2.19M 2.06% 6
2017
Q1
$45.8M Sell
368,026
-23,095
-6% -$2.76M 2.05% 3
2016
Q4
$45.3M Sell
391,121
-54,520
-12% -$6.07M 2.08% 5
2016
Q3
$46.6M Sell
445,641
-17,899
-4% -$1.94M 2.22% 5
2016
Q2
$45.7M Sell
463,540
-27,394
-6% -$2.83M 2.23% 6
2016
Q1
$49.1M Sell
490,934
-115,699
-19% -$11.9M 2.55% 4
2015
Q4
$72.7M Sell
606,633
-1,704
-0.3% -$197K 3.45% 3
2015
Q3
$65.8M Sell
608,337
-37,625
-6% -$4.67M 3.75% 3
2015
Q2
$74.8M Sell
645,962
-13,178
-2% -$1.51M 3.1% 5
2015
Q1
$76M Buy
659,140
+35,581
+6% +$4.25M 2.96% 4
2014
Q4
$69.8M Buy
623,559
+60,530
+11% +$6.38M 2.86% 4
2014
Q3
$53.4M Buy
563,029
+40,099
+8% +$3.62M 2.5% 6
2014
Q2
$44.9M Sell
522,930
-138,560
-21% -$10.5M 1.97% 5
2014
Q1
$46.2M Buy
661,490
+102,130
+18% +$8.09M 2.1% 5
2013
Q4
$47.3M Buy
559,360
+112,222
+25% +$8.88M 2.12% 4
2013
Q3
$34.4M Buy
447,138
+15,868
+4% +$1.11M 1.83% 4
2013
Q2
$25.2M Buy
+431,270
New +$26M 1.78% 6

Other funds holding CELG

Profund Advisors's CELG Position: Q4 2019 in Review

Profund Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 212,732 shares — an estimated $21.1M sold.

Profund Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $76M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Profund Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Profund Advisors sold 212,732 Celgene Corp shares in Q4 2019, an estimated $21.1M.
  • Profund Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Profund Advisors's Celgene Corp position peaked at $76M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Profund Advisors's 13F filing for Q4 2019, filed 18 Feb 2020.